Biotech Values

[DewDiligence]

Most emerging markets have low penetration rates of generic generics due to: i) the lack of a regulatory vehicle for automatic substitution; and ii) consumer mistrust of product quality. Instead, emerging-market countries generally have a strong market presence by branded generics from well-known multinational companies.

Please see #msg-61960541, #msg-39315651, #msg-61960541 and the reply threads to these posts for related stories.